F. Schöni-Affolter

2.2k total citations
18 papers, 889 citations indexed

About

F. Schöni-Affolter is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, F. Schöni-Affolter has authored 18 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 6 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in F. Schöni-Affolter's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). F. Schöni-Affolter is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (4 papers) and HIV/AIDS Research and Interventions (3 papers). F. Schöni-Affolter collaborates with scholars based in Switzerland, Germany and France. F. Schöni-Affolter's co-authors include Patrick Maisonneuve, Albert B. Lowenfels, Stacey R. Fitzsimmons, Joseph P. Neglia, Matthias Cavassini, Martin H. Schöni, Helen Kovari, Katharine Darling, Olivia Keiser and Philippe Bürgisser and has published in prestigious journals such as New England Journal of Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

F. Schöni-Affolter

18 papers receiving 869 citations

Peers

Countries citing papers authored by F. Schöni-Affolter

Since Specialization

Citations

This map shows the geographic impact of F. Schöni-Affolter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Schöni-Affolter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Schöni-Affolter more than expected).

Fields of papers citing papers by F. Schöni-Affolter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Schöni-Affolter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Schöni-Affolter. The network helps show where F. Schöni-Affolter may publish in the future.

Co-authorship network of co-authors of F. Schöni-Affolter

This figure shows the co-authorship network connecting the top 25 collaborators of F. Schöni-Affolter. A scholar is included among the top collaborators of F. Schöni-Affolter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Schöni-Affolter. F. Schöni-Affolter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization 2016 ·The Journal of Immunology ·(unknown), Valentina Cecchinato, Enos Bernasconi, Roberto F. Speck, Michele Proietti, Ulrike Sauermann, Gianluca D’Agostino, Gabriela Danelon, Tanja Rezzonico Jost, Fabio Grassi, Lorenzo Raeli, F. Schöni-Affolter, Christiane Stahl‐Hennig, Mariagrazia Uguccioni	19
2	Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors? 2016 ·Journal of Antimicrobial Chemotherapy ·(unknown), Daniel Hoffmann, Jürg Böni, Sabine Yerly, Vincent Aubert, F. Schöni-Affolter, Daniel Struck, Jens Verheyen, Thomas Klimkait, (unknown)	12
3	Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1 2016 ·Clinical Infectious Diseases ·(unknown), Martin Däumer, F. Schöni-Affolter, Jürg Böni, Meri Gorgievski-Hrisoho, G Martinetti, Alexander Thielen, Thomas Klimkait, (unknown)	15
4	Correlating HIV tropism with immunological response under combination antiretroviral therapy 2016 ·HIV Medicine ·(unknown), F. Schöni-Affolter, Jürg Böni, Meri Gorgievski-Hrisoho, G Martinetti, Manuel Battegay, Thomas Klimkait, (unknown)	10
5	Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case‐control study in the Swiss HIV cohort study 2015 ·International Journal of Cancer ·Gary M. Clifford, Silvia Franceschi, Olivia Keiser, F. Schöni-Affolter, M. Lise, Silvia Dehler, Fabio Levi, Seyed Mohsen Mousavi, Christine Bouchardy, Aline Wolfensberger, Katharine Darling, Cornelia Staehelin, Barbara Bertisch, Esther Kuenzli, Enos Bernasconi, Michael Pawlita, Matthias Egger, (unknown)	72
6	Risk Factors for Anal Cancer in Persons Infected With HIV: A Nested Case-Control Study in the Swiss HIV Cohort Study 2013 ·American Journal of Epidemiology ·Barbara Bertisch, Silvia Franceschi, M. Lise, P Vernazza, Olivia Keiser, F. Schöni-Affolter, Christine Bouchardy, Silvia Dehler, Fabio Levi, Gernot Jundt, S.M. Ess, Michael Pawlita, Helen Kovari, Gilles Wandeler, Alexandra Calmy, Matthias Cavassini, M Stöckle, Gary M. Clifford, (unknown)	96
7	Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection 2012 ·British Journal of Cancer ·(unknown), Gary M. Clifford, M. Lise, Silvia Franceschi, Matthias Egger, Christine Bouchardy, Dimitri Korol, Fabio Levi, S.M. Ess, Gernot Jundt, Gilles Wandeler, Jan Fehr, Patrick Schmid, Manuel Battegay, Enos Bernasconi, Matthias Cavassini, Alexandra Calmy, Olivia Keiser, F. Schöni-Affolter	58
8	Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection 2012 ·BMC Infectious Diseases ·(unknown), Jörg Schüpbach, Leslie R. Bisset, Martin Gebhardt, Stephan Regenass, Philippe Bürgisser, Meri Gorgievski, Thomas Klimkait, (unknown), G Martinetti, Christoph Niederhauser, Sabine Yerly, (unknown), D. Schultze, (unknown), F. Schöni-Affolter, Alexandra U. Scherrer, Huldrych F. Günthard	10
9	Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland 2011 ·Emerging infectious diseases ·Alain Kenfak-Foguena, F. Schöni-Affolter, Philippe Bürgisser, Andrea Witteck, Katharine Darling, Helen Kovari, Laurent Kaiser, (unknown), Luigia Elzi, (unknown), Josef Jost, Darius Moradpour, Florence Abravanel, Jacques Izopet, Matthias Cavassini, (unknown)	103
10	High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease 2011 ·BMC Infectious Diseases ·(unknown), Jörg Schüpbach, Leslie R. Bisset, Stephan Regenass, Philippe Bürgisser, Meri Gorgievski, Ingrid Steffen, (unknown), G Martinetti, Cyril Shah, Sabine Yerly, Thomas Klimkait, Martin Gebhardt, F. Schöni-Affolter, Martin Rickenbach	8
11	Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland 2011 ·PLoS ONE ·F. Schöni-Affolter, Olivia Keiser, Albert Mwango, Jeffrey S. A. Stringer, Bruno Ledergerber, Lloyd Mulenga, Heiner C. Bucher, Andrew O. Westfall, Alexandra Calmy, Andrew Boulle, Namwinga Chintu, Matthias Egger, H. Benjamin	55
12	Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland 2011 ·Emerging infectious diseases ·Alain Kenfak-Foguena, F. Schöni-Affolter, Philippe Bürgisser, Andrea Witteck, Katharine Darling, Helen Kovari, Laurent Kaiser, (unknown), Luigia Elzi, (unknown), Josef Jost, Darius Moradpour, Florence Abravanel, Jacques Izopet, Matthias Cavassini, (unknown)	108
13	Die ambulante ärztliche Versorgung der Kinder unter 16 Jahren in der Schweiz im Jahr 2004 2008 ·Schweizerische Ärztezeitung ·(unknown), F. Schöni-Affolter, André Busato, (unknown), (unknown)	1
14	[Swiss registry for patients with cystic fibrosis: design, programming, implementation and first examples of use]. 2000 ·PubMed ·F. Schöni-Affolter, P. Oswald, (unknown), Susi Kriemler, M H Schöni	2
15	Efficacy Trial of Bioresonance in Children with Atopic Dermatitis 1997 ·International Archives of Allergy and Immunology ·Martin H. Schöni, Wilfried H. Nikolaizik, F. Schöni-Affolter	32
16	Cancer risk in patients with cystic fibrosis: the European data. CF/CSG Group. 1996 ·PubMed ·Martin H. Schöni, Patrick Maisonneuve, F. Schöni-Affolter, Albert B. Lowenfels	27
17	The Risk of Cancer among Patients with Cystic Fibrosis 1995 ·New England Journal of Medicine ·Joseph P. Neglia, Stacey R. Fitzsimmons, Patrick Maisonneuve, (unknown), F. Schöni-Affolter, (unknown), Albert B. Lowenfels	255
18	Intracellular free calcium levels in mononuclear cells of patients with cystic fibrosis and normal controls 1987 ·Cell Calcium ·Martin H. Schöni, F. Schöni-Affolter, D Jeffery, Sidney Katz	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact